Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 457 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Score Clear all

Conditions: Depression
Interventions: Citalopram, Methylphenidate (MPH), Placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 60 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Rheumatoid Arthritis, Cardiovascular Disease
Interventions: Not listed
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Inflammation
Interventions: Influenza Virus Vaccine; Biological
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2015
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Acute Coronary Syndrome, Depressive Symptoms
Interventions: Cognitive Behavioral Therapy (CBT), Antidepressant Medication, Standard Care, Depressive symptom screener, No intervention; Other · Drug
Lead sponsor: Columbia University; Other
Eligibility: 21 Years and older
Enrollment: 1,501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 4
States / cities: Bloomington, Minnesota • New York, New York • Henderson, North Carolina + 1 more

Conditions: Pancreatitis
Interventions: Early cholecystectomy with IOC, Late cholecystectomy with IOC; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Communication Research
Interventions: nurse-led communication strategy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Exercise Therapy
Interventions: Metronome; Device
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Crohn's Disease
Interventions: Vedolizumab, placebo; Drug
Lead sponsor: Marc Schwartz; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Coronavirus Infection, COVID, Covid-19, SARS-CoV-2
Interventions: Point-of-Care Ultrasonography (POCUS); Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Atherosclerosis, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 20 Years to 85 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep Problems
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 4 Years to 9 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 3
States / cities: New York, New York • Portland, Oregon • Houston, Texas

Conditions: Cushing's Disease, Cushing Syndrome, Cushing Disease
Interventions: Cushing's QoL (Quality of Life Questionnaire), Nottingham Health Profile (NHP), Hospital Anxiety and Depression Scale (HADS), Perceived Stress Scale (PSS), Barratt's Impulsivity Scale (BIS), Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI), State Food Craving Questionnaire-State (FCQ-S), Trait Food Craving Questionnaire-Trait (FCQ-T), Visual Analogue Scale (VAS), Sensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 14 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Epilepsy, Cognitive Deficits, Attention Deficits
Interventions: Methylphenidate; Drug
Lead sponsor: Kimford Jay Meador; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Coronary Artery Disease, Polygenic Risk Score, Heart Diseases, Coronary Disease, Myocardial Infarction, Cardiovascular Diseases
Interventions: Disclosure of integrate risk score for coronary artery disease; Genetic
Lead sponsor: MyOme; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Rochester, Minnesota • Philadelphia, Pennsylvania

Conditions: Gynecologic Oncology Patient
Interventions: Integrated psychological care, Surveys, Blood draw, Fresh tissue from ovary; Behavioral · Other · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Inflammatory Bowel Diseases
Interventions: Baseline blood sample, Baseline intestinal biopsies, Crohn's disease activity index (CDAI), Post treatment blood sample, Post treatment intestinal biopsies, Baseline stool sample, Post treatment stool sample; Diagnostic Test · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Alzheimer Disease
Interventions: Challenge A - low calorie Ensure®, Challenge B - Ensure® plus ketone esters (KE), PET Scan, Cognitive Testing - FCSRT, Story Recall, BVRT, CogState One Card Learning; Dietary Supplement · Procedure · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stress Disorders, Post-Traumatic, Depression, Anxiety
Interventions: Family Care Rituals; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Chicago, Illinois • Providence, Rhode Island

Conditions: Pain, Back
Interventions: Auricular acupuncture, Visual Analog Scale for Pain, Roland-Morris Disability Questionnaire; Device · Behavioral
Lead sponsor: Korey Kennelty; Other
Eligibility: 18 Years to 115 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Drinking, Binge
Interventions: Presentation of alcohol-related and neutral stimuli; Other
Lead sponsor: Rochester Institute of Technology; Other
Eligibility: 18 Years to 25 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Graft-versus-host Disease
Interventions: Neihulizumab, 3 mg/kg, Neihulizumab, 6 mg/kg, Neihulizumab, 9 mg/kg, Neihulizumab; Biological · Drug
Lead sponsor: Sameem M. Abedin, MD; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Disc Degeneration, Low Back Pain
Interventions: Exercise; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 85 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Preeclampsia
Interventions: Mindfulness training, Garmin Vivoactive 4 watch; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Providence, Rhode Island • Milwaukee, Wisconsin

Conditions: Morning Sickness
Interventions: Bonjesta, Placebo; Drug
Lead sponsor: Duchesnay Inc.; Industry
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 274 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 10
States / cities: Burbank, California • Hialeah, Florida • Miami, Florida + 7 more

Search by objective public record fields.

Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression

Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis

Vaccine Efficacy in Diabetic and Elderly Patients

Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes

Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis

Using a Nurse-Led Communication Strategy for Surrogates in the Intensive Care Unit

Effects of a Metronome on Functional Outcomes in Aquatic Therapy

Vedolizumab Post Op Study

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Methylphenidate Treatment of Attention Deficits in Epilepsy

Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)

Psychological Services Integration in Gynecological Oncology Clinics

Cytokines and Genes in Therapeutic Response in Crohn's Disease

The Brain Ketone Body Challenge Imaging Study

Prospective Evaluation of Family Care Rituals in the ICU

Implementing Group Battlefield Acupuncture in CCRCs for the Treatment of Chronic Lower Back Pain

Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

Lumbar Spine Muscle Degeneration Inhibits Rehabilitation-Induced Muscle Recovery

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents